Profile: Biogen Idec deals with discovery, development, manufacturing and commercialization of innovative therapies. We focus mainly on oncology, neurology and immunology. Our products address diseases such as multiple sclerosis (MS), lymphoma, and rheumatoid arthritis. Our Avonex® is prescribed for treating relapsing forms of MS to slow the progression of disability and reduce relapses. It is also approved for patients who have their first clinical MS attack and have a brain MRI scan consistent with MS. It should be used with caution in patients with depression or other mood disorders and in patients with seizure disorders. It should not be used by pregnant women. Our Rituxan® is approved for treatment of relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin's lymphoma (NHL).